Cryoconcepts LP appears in FDA device records as the applicant for 510(k) premarket notifications covering cryosurgical units and accessories for wart and skin tag removal. The company's own published site describes cryosurgery and cryotherapy products across over-the-counter, physician office, medical and day spa, and veterinary markets, and states operations since 1991. The documented regulatory footprint in the collected filings is narrow: one linked 510(k) record, K260520, decided substantially equivalent on October 27, 2026. That count reflects the collected filings as of the snapshot date, not total company sales or the full portfolio. [1][2][4]

Documented 510(k) clearances

K260520 covers Skin Clinic Nitro Clear for Warts and Skin Tags, a Class II cryosurgical unit and accessories under product code GEH and regulation 21 CFR 878.4350. The FDA record lists a Traditional clearance type, a decision of substantially equivalent (SESE) dated October 27, 2026, and a submission received February 17, 2026. The advisory committee is General, Plastic Surgery. The filing address is 1100 Conroy Pl., Easton, PA 18040, with R Sam Niedbala listed as contact. [1]

An earlier clearance, K242932, covers Skin Clinic NitroClear & Private Label Versions, also Class II, product code GEH, regulation 21 CFR 878.4350. The FDA clearance letter is dated April 15, 2025, for a submission dated March 16, 2025 and received March 19, 2025, addressed to Sam Niedbala as CEO at the same Easton, Pennsylvania address. The letter states the device was found substantially equivalent to legally marketed predicate devices for the indications for use in the enclosure. [2]

Bench and in vitro comparison data

The K242932 record describes comparisons between predicate Skin Clinic devices and the Skin Clinic Nitro Clear Wart Remover product. Per that document, bench testing showed equivalent or lower temperatures could be attained with the subject device, and an in vitro test indicated the subject and predicate devices killed cells embedded in an agar matrix over the time course of a standard treatment time. These are the filing's stated test results, not independent clinical outcome data. [2]

Company-published product scope

CryoConcepts' published site states the company has worked in cryosurgery and cryotherapy since 1991 and describes products for over-the-counter, physician office, medical and day spa, and veterinary markets. Its over-the-counter page names the Skin Clinic Freeze 'n Clear line and a Skin Clinic Ultimate Skin Tag Remover, and the site also references Vet CryOmega and dual-delivery EPA/HFC-compliant devices. These descriptions come from the manufacturer's own documentation. [4][7][8]

The same published material states CryoConcepts is a private label supplier of cryo wart and skin tag removers, citing more than 30 SKUs distributed across 47 countries. Those figures are company claims published on its site; they are not verified in the FDA records reviewed here. The site also notes a January 2025 EPA action affecting certain cryosurgical products. [4][8]

Applicant identity and record limits

FDA records identify Cryoconcepts LP as the legal applicant on the cited submissions; the Easton address appears as a filing address, and no separate headquarters designation is established by these records. The collected filings contain one linked 510(k) record with a SESE decision, and that single-record count is a snapshot of the collected data rather than a measure of total clearances, sales or safety performance. No recall records appear in the collected sample. [1][2][3]